GleamWall
中文EN

AVTR Avantor, Inc.

Laboratory Analytical Instruments · NYSE · SEC CIK 1722482 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY0.9%
TTM net income YoY510.2%
TTM EPS YoY484.6%
Revenue 3-yr CAGR-1.9%
Net income 3-yr CAGR-2.5%

Margins

Gross margin31.6%
Operating margin7.3%
Net margin5.1%
FCF margin6.6%
EBITDA margin13.7%

Returns

ROE5.9%
ROA2.9%
ROIC (approx.)5.3%
Asset turnover0.57x

Leverage & solvency

Liabilities / assets49.8%
Debt / equity0.63x
Current ratio1.89x
Interest coverage3.00x

Cash quality & payout

Operating cash flow / net income1.73x
Accruals ratio-2.1%
Payout ratio—
Capex / revenue2.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$1.70B$1.69B$1.58B$1.66B$1.62B$1.68B$1.58B$1.69B
Cost of revenue$1.16B$1.16B$1.08B$1.14B$1.10B$1.13B$1.05B$1.12B
Gross profit$534.80M$537.00M$500.70M$523.90M$526.50M$554.10M$534.90M$562.90M
SG&A expense$395.30M$415.20M$401.20M$392.40M$390.30M$425.30M$387.50M$371.40M
Operating income$139.50M$121.80M$99.50M$126.40M-$648.80M$128.80M$147.40M$638.10M
Interest expense$39.90M$39.40M$42.90M$40.00M$44.20M$43.40M$42.20M$44.90M
Pretax income$98.00M$81.20M$55.50M$80.80M-$689.50M$81.70M$85.70M$584.20M
Income tax-$105.40M$43.10M$12.20M$28.40M$22.30M$17.00M$21.20M$83.80M
Net income$203.40M$38.10M$43.30M$52.40M-$711.80M$64.70M$64.50M$500.40M
EBITDA$244.80M$227.40M$204.50M$229.70M-$544.30M$231.50M$247.10M$739.00M
EPS (basic)0.300.060.06—-1.040.090.09—
EPS (diluted)0.300.060.06—-1.040.090.09—
Weighted avg. shares (diluted)680.90M677.20M676.80M—681.70M681.80M682.40M—
Balance sheet
Cash & equivalents$464.30M$306.80M$279.30M$365.40M$254.70M$452.20M$318.50M$264.70M
Receivables$1.12B$1.14B$1.10B$1.07B$1.08B$1.15B$1.10B$1.03B
Inventory$854.80M$828.70M$810.30M$818.20M$795.50M$779.80M$750.10M$731.50M
Current assets$2.59B$2.46B$2.40B$2.45B$2.26B$2.51B$2.28B$2.15B
PP&E, net$778.90M$772.10M$766.20M$766.80M$761.60M$759.00M$736.30M$708.10M
Goodwill$4.93B$4.94B$4.95B$4.99B$4.98B$5.76B$5.61B$5.54B
Intangibles$2.84B$2.92B$3.01B$3.10B$3.17B$3.26B$3.24B$3.27B
Total assets$11.63B$11.60B$11.66B$11.79B$11.68B$12.78B$12.33B$12.11B
Current liabilities$1.37B$1.38B$1.37B$1.38B$1.52B$2.58B$2.03B$2.01B
Short-term debt$35.00M$37.00M$37.00M$30.80M$219.80M$1.25B$827.50M$821.10M
Long-term debt$3.65B$3.66B$3.78B$3.92B$3.64B$2.99B$3.28B$3.23B
Total debt$3.68B$3.70B$3.82B$3.95B$3.86B$4.24B$4.11B$4.06B
Total liabilities$5.79B$5.97B$6.07B$6.23B$6.11B$6.49B$6.23B$6.16B
Shareholders' equity$5.84B$5.63B$5.59B$5.57B$5.57B$6.29B$6.10B$5.96B
Net debt$3.22B$3.39B$3.54B$3.58B$3.60B$3.79B$3.79B$3.79B
Shares outstanding——682.90M682.00M681.90M681.60M681.50M680.80M
Cash flow statement
Operating cash flow$195.10M$178.20M$58.70M$152.70M$207.40M$154.40M$109.30M$173.30M
Capital expenditure$38.90M$37.60M$33.50M$35.50M$35.70M$29.60M$28.00M$27.50M
Free cash flow$156.20M$140.60M$25.20M$117.20M$171.70M$124.80M$81.30M$145.80M
Investing cash flow-$38.50M-$37.30M-$32.70M-$39.70M-$33.30M-$28.60M-$28.90M$558.50M
Financing cash flow$1.80M-$112.40M-$107.20M$700,000-$369.60M-$6.90M-$33.60M-$755.30M
Depreciation & amortization$105.30M$105.60M$105.00M$103.30M$104.50M$102.70M$99.70M$100.90M
Stock-based compensation$12.50M$15.40M$8.60M$11.30M$7.30M$15.50M$12.40M$11.10M

Free plan shows the latest 8 periods; Pro shows all 35 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.